Search
for
Sort by
Research 331–360 of 1000+
- Treatment of severe alopecia areata with baricitinib
- Alopecia Areata Increases the Risk of Stroke: a 3-year Follow-Up Study
- Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Population Using Insurance Claims
- Systematic review and quality analysis of studies on the efficacy of topical diphenylcyclopropenone treatment for alopecia areata
- The Functional Relevance of the Type 1 Cytokines IFN-γ and IL-2 in Alopecia Areata of C3H/HeJ Mice
- Effects of mesenchymal stem cell therapy on alopecia areata in cellular and hair follicle organ culture models
- <i>Zizyphus jujuba</i>protects against ibuprofen-induced nephrotoxicity in rats
- Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity
- Low-Dose Systemic Methotrexate Therapy for Recalcitrant Alopecia Areata
- Beau's Lines
- Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Case report: pemphigus vulgaris in an adolescent
- Multiple minute digitate hyperkeratosis
- HLA-B27 Antigen in Women With Ankylosing Spondylitis
- THE FREQUENCY OF VISCERAL AND PHENOTYPIC MARKERS IN PATIENTS WITH THE COMBINATION OF UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE AND GASTROESOPHAGEAL REFLUX DISEASE
- The Influence of Race and Sex on the Side Effect Profile of Methotrexate in the Treatment of Uveitis
- Atopic dermatitis and risk of autoimmune diseases: a systematic review and meta-analysis
- Alopecia caused by isoniazid
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Erosive Pustular Dermatosis of the Scalp
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Topical tofacitinib in treatment of alopecia areata
- The serum evaluation of sex hormones including DHEAs, DHT, testosterone in oral lichen planus patients
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Hair Growth in a Patient with Alopecia Areata on Tocilizumab
- Leflunomide: an unlikely trigger and mechanistically a beneficial drug for alopecia areata
- 075 Clinical investigation of JAK inhibitor Tofacitinib in scarring alopecias
- Alopecia Associated with Sulfasalazine
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article